Absorb Randomized Controlled Trial – A Clinical Evaluation of Absorb BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects with de novo Native Coronary Artery Lesions

Compare treatment of lesions (narrowing) in the coronary arteries using bioresorbable stents versus metallic drug-eluting stents


Sponsor: Abbott Vascular

Keywords: Stent, heart, cardiac, Absorb, bioresorbable, absorbable stent, cardiovascular, angiogram, angioplasty

Cardiology (Heart)
Gerald Gacioch, MD
Active / Closed to Enrollment
Center for Clinical Research